Rocket Doctor AI closes US$1.69M debenture tranche weeks after launch
What's the deal? Rocket Doctor AIDealroom has a profile for this one. Try Dealroom → (formerly Treatment.com AIDealroom has a profile for this one. Try Dealroom →) closed the first tranche of its private placement of unsecured convertible debentures in August 2026, raising US$1.66M in gross proceeds. The listed digital health company trades on the Canadian Securities Exchange, OTC Markets and the Frankfurt Stock Exchange.
The terms. The debentures carry 12% annual interest, payable at maturity 12 months after issuance. Principal and accrued interest may convert into units at US$0.51 each, with each unit comprising one common share and one warrant exercisable at US$0.55 for 12 months.
Use of proceeds. The company will use the net proceeds for working capital and general and administrative expenses, primarily focused on its US growth plans. It paid US$63.6K in arm's-length finder fees on the tranche.
Why now? The August 6, 2026 close follows the July 28, 2026 announcement of the offering and completes an oversubscribed first tranche.
Read more: GlobeNewswire
Image credit: Generated with Gemini
